Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D vs Vancomycin

## Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D vs Vancomycin: Overview

This comparison examines the pharmacological differences between **Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D** and **Vancomycin**.

## Mechanism of Action

**Vancomycin**: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.

## Pharmacokinetics

**Half-life**: Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A; Vancomycin — 4-6 hours.

## Chemical Properties

**Molecular Formula**: Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A; Vancomycin — C66H75Cl2N9O24.

**Molecular Weight**: Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A; Vancomycin — 1449.2500 g/mol.

**Type**: Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — Vaccine component; Vancomycin — Small molecule.